EcoDrugPlus

Ensembl ID : ENSFHEG00000002403
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSFHEG00000017464
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSFHEG00000020840
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSFHEG00000017534
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSFHEG00000004868
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSFHEG00000000285
Gene Symbol: -
Cross references: -
230 Possible Orthologues:

Ensembl ID : ENSFHEG00000020844
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSFHEG00000020497
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSFHEG00000000579
Gene Symbol: -
Cross references: -
116 Possible Orthologues:

Ensembl ID : ENSFHEG00000001442
Gene Symbol: -
Cross references: -
246 Possible Orthologues:

Ensembl ID : ENSFHEG00000021838
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSFHEG00000004368
Gene Symbol: -
Cross references: -
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).